PTSM: Pharmaceutical Technology Sourcing and Management-07-01-2015

SGS Life Science Services expands cGMP chemistry and biotechnology testing facilities in Shanghai.

A 25,000-sq-ft cargo facility at Philadelphia International Airport offers different levels of temperature storage.

More biopharma companies choose outside service providers for assay testing.

Safer reagents and reaction conditions are making many hazardous transformations possible.

Regulators and industry seek to streamline and harmonize oversight of manufacturing changes for firms that adopt modern production methods.

Bylo has been selected to lead the GS1 Healthcare US Industry Initiative, focused on driving adoption and usage of GS1 Standards in healthcare.

The European Medicines Verification Organization has signed agreements with service providers to establish blueprint systems in compliance with the Falsified Medicines Directive.

Novasep's new antibody drug conjugate facility at its site in Le Mans, France will be commissioned in 2016.

Pharmacy associates say more education regarding the transactional requirements of DSCSA is needed.

apceth has completed a major GMP inspection for two medicinal products. The two cell and gene therapy products are now included in the company’s GMP manufacturing license according to §13 of the German Medicines Act (AMG).

The agency clarifies its requirements for allowable excess volume and labeled vial fill size in injectables and biologics.

Reach Separations has announced plans to double its laboratory space at its Nottingham facility as a result of increased demand for its specialist purification services.

The combined company has been created through the integration of Huntingdon Life Sciences and Harlan Laboratories announces a new company name.

The agency takes action against websites that illegally sell unapproved medications.

Lonza’s planned facility will be used to develop and manufacture viral gene therapies and virally modified cell therapies

Catalent’s Singapore facility is awarded GMP certification.

Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.

West Pharmaceutical began construction on its component manufacturing facility located in Waterford, Ireland.

A new GMP facility in Massachusetts will produce enzymes and other reagents for in-vitro diagnostics.